Trials / Completed
CompletedNCT00124059
Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.
A Double-Blind Study of Quetiapine Fumarate (Seroquel) for the Treatment of Type A vs.Type B Alcoholics.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether seroquel is effective in the treatment of type A and type B alcohol dependence.
Detailed description
The purpose of this study is to obtain preliminary data regarding the safety, efficacy and tolerability of quetiapine \[Seroquel (SQL)\] in treating Type A vs B alcohol dependent outpatients seeking treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Seroquel | 400mg/day quetiapine |
| DRUG | Placebo | 400mg/day placebo |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2005-09-01
- Completion
- 2005-10-01
- First posted
- 2005-07-26
- Last updated
- 2015-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00124059. Inclusion in this directory is not an endorsement.